Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Cited In for PubMed (Select 12378124)

1.

Inflammation, ectopic fat and lipid metabolism: view from the chair.

Picard F, Deshaies Y.

Int J Obes Suppl. 2012 Dec;2(Suppl 2):S29-S30.

2.

Serum antinucleosome-specific antibody as a marker of autoimmunity in children with autism.

AL-Ayadhi LY, Mostafa GA.

J Neuroinflammation. 2014 Apr 3;11:69. doi: 10.1186/1742-2094-11-69.

3.

My experience learning about autism.

Rossignol DA.

Glob Adv Health Med. 2013 Nov;2(6):74-7. doi: 10.7453/gahmj.2013.090.

4.

Peptides' role in autism with emphasis on exorphins.

Reichelt KL, Tveiten D, Knivsberg AM, Brønstad G.

Microb Ecol Health Dis. 2012 Aug 24;23. doi: 10.3402/mehd.v23i0.18958. eCollection 2012.

5.

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.

Macfabe DF.

Microb Ecol Health Dis. 2012 Aug 24;23. doi: 10.3402/mehd.v23i0.19260. eCollection 2012.

6.

Antibodies against food antigens in patients with autistic spectrum disorders.

de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, Abbadessa S, Medici N, Lammers KM, Schiraldi C, Iardino P, Marotta R, Tolone C, Fasano A, Pascotto A, Bravaccio C.

Biomed Res Int. 2013;2013:729349. doi: 10.1155/2013/729349. Epub 2013 Aug 1.

7.

Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.

Essa MM, Subash S, Braidy N, Al-Adawi S, Lim CK, Manivasagam T, Guillemin GJ.

Int J Tryptophan Res. 2013 Jul 21;6(Suppl 1):15-28. doi: 10.4137/IJTR.S11355. Print 2013.

8.

Gluten- and casein-free dietary intervention for autism spectrum conditions.

Whiteley P, Shattock P, Knivsberg AM, Seim A, Reichelt KL, Todd L, Carr K, Hooper M.

Front Hum Neurosci. 2013 Jan 4;6:344. doi: 10.3389/fnhum.2012.00344. eCollection 2012.

9.

Structural, genetic, and functional signatures of disordered neuro-immunological development in autism spectrum disorder.

Saxena V, Ramdas S, Ochoa CR, Wallace D, Bhide P, Kohane I.

PLoS One. 2012;7(12):e48835. doi: 10.1371/journal.pone.0048835. Epub 2012 Dec 4.

10.

Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, Bothwell AL, Kawikova I.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):555-64. doi: 10.1089/cap.2010.0134. Epub 2011 Nov 9.

11.

NF-κB signaling in the brain of autistic subjects.

Malik M, Tauqeer Z, Sheikh AM, Wen G, Nagori A, Yang K, Brown WT, Li X.

Mediators Inflamm. 2011;2011:785265. doi: 10.1155/2011/785265. Epub 2011 Oct 20. Erratum in: Mediators Inflamm. 2013;2013:691975.

12.

Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia.

El-Ansary AK, Ben Bacha AG, Al-Ayadhi LY.

J Neuroinflammation. 2011 Oct 15;8:142. doi: 10.1186/1742-2094-8-142.

13.
14.

IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation.

Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, Li X.

J Neuroinflammation. 2011 May 19;8:52. doi: 10.1186/1742-2094-8-52.

15.

Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Mostafa GA, Al-Ayadhi LY.

J Neuroinflammation. 2011 Apr 25;8:39. doi: 10.1186/1742-2094-8-39.

16.

The immune system's role in the biology of autism.

Goines P, Van de Water J.

Curr Opin Neurol. 2010 Apr;23(2):111-7. doi: 10.1097/WCO.0b013e3283373514. Review.

17.

Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Enstrom AM, Onore CE, Van de Water JA, Ashwood P.

Brain Behav Immun. 2010 Jan;24(1):64-71. doi: 10.1016/j.bbi.2009.08.001. Epub 2009 Aug 8.

18.

Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, Neubrander J, Madren EM, Hintz G, Grushkin B, Mumper EA.

BMC Pediatr. 2009 Mar 13;9:21. doi: 10.1186/1471-2431-9-21. Erratum in: BMC Pediatr. 2012 Dec;42(4):236.

19.

Autistic enterocolitis: fact or fiction?

Galiatsatos P, Gologan A, Lamoureux E.

Can J Gastroenterol. 2009 Feb;23(2):95-8. Review.

20.

Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.

Ashwood P, Schauer J, Pessah IN, Van de Water J.

J Neuroimmunol. 2009 Mar 31;208(1-2):130-5. doi: 10.1016/j.jneuroim.2008.12.012. Epub 2009 Feb 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk